What's new in the treatment of advanced prostate cancer?

被引：21

作者：

Sternberg, CN ^{[1
]}

机构：

[1] San Camillo Forlanini Hosp, Vincenzo Pansadoro Fdn, Dept Med Oncol, I-00165 Rome, Italy

来源：

EUROPEAN JOURNAL OF CANCER | 2003年 / 39卷 / 02期

关键词：

prostate cancer; treatment; hormone-refractory; second-line; immunotherapy; chemotherapy; gene therapy; new agents;

D O I：

10.1016/S0959-8049(02)00665-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Increased insight into the biology of prostate cancer and the emergence of new therapeutic strategies and chemotherapeutic agents has changed approaches in treating patients with advanced prostate cancer. After secondary hormonal manipulations, new approaches include: second-line hormonal therapy, chemotherapy, immunotherapy with granulocyte macrophage-colony stimulating factor (GM-CSF) therapy, dendritic cell therapy, gene vaccination therapy, inhibition and/or blockade of growth factor receptors or growth factor receptor pathways, inhibition of neo-angiogenesis and inhibition of invasion and metastases. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：136 / 146

页数：11

共 112 条

[71]

2-Z

[72] Docetaxel and exisulind in hormone-refractory prostate cancer [J].

Ryan, CW ;

Stadler, WM ;

Vogelzang, NJ .

SEMINARS IN ONCOLOGY, 2001, 28 (04) :56-61

[73] Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α [J].

Sallusto, Federica ;

Lanzavecchia, Antonio .

JOURNAL OF IMMUNOLOGY, 2018, 200 (03) :887-896

[74] EPIDERMAL GROWTH FACTOR-RELATED PEPTIDES AND THEIR RECEPTORS IN HUMAN MALIGNANCIES [J].

SALOMON, DS ;

BRANDT, R ;

CIARDIELLO, F ;

NORMANNO, N .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1995, 19 (03) :183-232

[75] Gene therapy for osteoinduction [J].

Scaduto, AA ;

Lieberman, JR .

ORTHOPEDIC CLINICS OF NORTH AMERICA, 1999, 30 (04) :625-+

[76]

SCHELLHAMMER P, 2002, P AN M AM SOC CLIN, V21, pA183

[77]

Scher H I, 1985, Semin Urol, V3, P239

[78] FLUTAMIDE WITHDRAWAL SYNDROME - ITS IMPACT ON CLINICAL-TRIALS IN HORMONE-REFRACTORY PROSTATE-CANCER [J].

SCHER, HI ;

KELLY, WK .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1566-1572

[79] Nutrition and respiratory disease [J].

Schols, AMWJ .

CLINICAL NUTRITION, 2001, 20 :173-179

[80]

Schulman C, 2002, J UROLOGY, V167, P176

← 3 4 5 6 7 8 9 10 11 12 →